[1] Tu WJ,Wang LD,YAN F,et al.China stroke surveillance report 2021[J].Military Med Res,2023,10(1):33. [2] Bruning T,Al-Khaled M.Do statins reduce the mortality rate in stroke patients treated with systemic thrombolysis in a 5-year[J].Neural Regen Res ,2021,16(9):1807~1812. [3] Zi WJ,Song JX,Kong WL,et al.Tirofiban for stroke without large or medium-sized vessel occlusion[J].N Engl J Med,2023,388(22):2025~2036. [4] Wang YJ,Li ZX,Gu HQ,et al.China stroke statistics:an update on the 2019 report from the national center for healthcare quality management in neurological diseases,China national clinical research center for neurological diseases,the Chinese stroke association,national center for chronic and non-communicable disease control and prevention,Chinese center for disease control and prevention and institute for global neuroscience and stroke collaborations[J].Stroke Vasc Neurol,2022,7(5):415~450. [5] Shehjar F,Maktabi B,Rahman ZA,et al.Stroke: molecular mechanisms and therapies:update on recent developments[J].Neurochem Int,2023,162:105458. [6] 付群,刘尊敬,崔丹.老年急性脑梗死患者血清CCL2、CCL3表达水平与脑梗死体积、神经功能缺损程度的关系[J].卒中与神经疾病, 2019,26(1):8~12. [7] 张乐石,殷艳玲,常明则.血清TIMP-1水平和脑梗死体积与老年患者脑卒中后认知功能障碍发生的关系[J].检验医学与临床,2024,21(15):2237~2242+2247. [8] Du XY,Liu QJ,Li Q,et al.Prognostic value of cerebral infarction coefficient in patients with massive cerebral infarction[J].Clin Neurol Neurosurg,2020,196:106009. [9] Mochetti MM,Silva EGP,Correa AAF,et al.Neuron-specific enolase at admission as a predictor for stroke volume,severity and outcome in ischemic stroke patients:a prognostic biomarker review[J].Sci Rep,2024,14(1):2688. [10] Taiwo YF, Osaigbovo GO, Gabkwet AE,et al.Volume of acute ischemic stroke lesion and patients' outcome at jos university teaching hospital:a cranial computed tomography study[J].West Afr J Med ,2020,37(5):555~559. [11] 钟迪,张舒婷,吴波.《中国急性缺血性脑卒中诊治指南2018》解读[J].中国现代神经疾病杂志,2019,19(11):897~901. [12] Karaszewski B,Wyszomirski A,JabłOñski B,et al.Efficacy and safety of intravenous rtPA in ischemic strokes due to small-vessel occlusion:systematic review and meta-analysis[J].Transl Stroke Res ,2021,12(3):406~415. [13] Cheng B,Pinnschmid TH,KöNnigsberg A,et al.Estimating nocturnal stroke onset times by magnetic resonance imaging in the WAKE-UP trial[J].Int J Stroke,2022,17(3):323~330. [14] Fan H,Su P,Lin DDM,et al.Simultaneous hemodynamic and structural imaging of ischemic stroke with magnetic resonance fingerprinting arterial spin labeling[J].Stroke,2022,53(6):2016~2025. [15] Wyss A,Dawson J,Arba F,et al.Combining neurovascular and neurodegenerative magnetic resonance imaging measures in stroke[J] ,Stroke,2019,50(5):1136~1139. [16] 彭菲,王瑞萍,张磊.急性脑梗死患者病灶体积及预后的MRI评价[J].中国CT和MRI杂志,2024,22(2):36~38. [17] 方文,陈桢,李鹏飞,等.血清炎症因子和S100B与进展性脑梗死患者神经功能缺损、梗死体积及预后的相关性研究[J].临床和实验医学杂志,2023,22(14):1469~1474. [18] 钟曌,郭继勃,郭昊,等.急性缺血性脑卒中患者血清Kruppel样转录因子2水平表达与脑梗死体积及预后的相关性研究[J].现代检验医学杂志,2023,38(6):1~5,+12. [19] Thayabaranathan T,Kim J,Cadilhac DA,et al.Global stroke statistics 2022[J].Int stroke,2022, 17(9):946~956. [20] 梁菲菲,孙子慧,包曼.急性脑梗死部位、体积与临床预后的关系[J].河北医药,2024,46(3):384~387. [21] Fan RL,Gu JJ,Zhang JX,et al.Risk factors for stroke outcomes in adults:Stroke in China[J].Medicine,2023,102(49):e36606. [22] Lin XR,Wang HX,Rong XM,et al.Exploring stroke risk and prevention in China:insights from an outlier[J].Aging,2021,13(11):15659~15673. [23] Tu WJ,Wang LD.China stroke surveillance report 2021[J].Mil Med Res ,2023,10(1):33. [24] Liu M,Xu Z,Wang L,et al.Cottonseed oil alleviates ischemic stroke injury by inhibiting the inflammatory activation of microglia and astrocyte[J].J Neuroinflammation,2020,17(1):270. [25] 宗寿健,孙贵芝,于丽红,等.急性脑梗死患者血清同型半胱氨酸和神经元特异性烯醇化酶水平与梗死面积和神经功能缺损程度的关系[J].河南医学研究,2020,29(29):5398~5401. [26] 郑德泉,江华,韩玉惠,等.老年急性脑梗死患者血清Del-1和IL-17水平变化及与梗死面积和预后的关系[J].中国实用神经疾病杂志,2024,27(1):26~30. |